PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis (PRIME-PPF)
PRIME-PPF: PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Listed as NCT06855329, this observational or N/A phase trial focuses on Interstitial Lung Disease and Progressive Pulmonary Fibrosis and remains actively recruiting participants. Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS, it has been updated 5 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Oct 2025 — Present [monthly]
Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2025 — Jun 2025 [monthly]
Not Yet Recruiting
-
Apr 2025 — May 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Johannes Gutenberg University Mainz
- University of Massachusetts, Worcester
- University of Michigan
- University of Virginia
For direct contact, visit the study record on ClinicalTrials.gov .